Servicenow Insider Sold Shares Worth $481,636, According to a Recent SEC Filing-February 2024-www.financetom.com

Servicenow Insider Sold Shares Worth $481,636, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Servicenow Insider Sold Shares Worth $481,636, According to a Recent SEC Filing

Jan 17, 2025 1:53 PM

04:39 PM EST, 01/17/2025 (MT Newswires) -- Jacqueline P Canney, Chief People Officer, on January 15, 2025, sold 455 shares in Servicenow ( NOW ) for $481,636. Following the Form 4 filing with the SEC, Canney has control over a total of 3,027 shares of the company, with 3,027 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1373715/000137371525000002/xslF345X05/wk-form4_1737149600.xml

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Regeneron Pharmaceuticals Partners With Hansoh Pharma to Develop GLP-1 Drug

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Regeneron Pharmaceuticals Partners With Hansoh Pharma to Develop GLP-1 Drug

Jun 2, 2025

08:03 AM EDT, 06/02/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Monday that it agreed with Hansoh Pharmaceutical Group to develop and commercialize the GLP-1 receptor agonist HS-20094 outside of mainland China, Hong Kong, and Macau. The drug, currently in phase 3 trials for obesity and phase 2 study for diabetes, has shown promising efficacy and safety profiles...

Deals of the day-Mergers and acquisitions

Jun 2, 2025

June 2 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1200 GMT on Monday: ** British investment firm Rosebank Industries said it has restarted talks to buy U.S.-based Electrical Components International, which makes wire harnesses, for under $1.9 billion. ** France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for over $9 billion to boost...

Market Chatter: HSBC to Allocate $4 Billion to Private Credit Lending

Jun 2, 2025

08:06 AM EDT, 06/02/2025 (MT Newswires) -- HSBC ( HSBC ) will allocate $4 billion to its private credit funds, Reuters reported Monday, citing an interview with Nicolas Moreau, chief executive of the company's asset management business. It's an arms race, he said, according to Reuters. Moreau said the new funds will initially target clients in the UK and Asia,...